Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,445 total articles
InflaRx N.V., a biopharmaceutical company specializing in anti-inflammatory therapies targeting the complement system, has completed a $150 million underwritten offering of 75 million ordinary shares priced at $2.00 each. The proceeds are intended to support the advancement of its drug pipeline, working capital, and general corporate needs. The off…
Micropolis AI Robotics, a UAE-based company traded on the NYSE, was highlighted as a leading technology success at the Make it in the Emirates 2026 event. The company showcased its advanced autonomous mobile robots and AI systems, receiving significant government and industry attention. Notably, Micropolis secured a $1.2 million contract with EMSTE…
ALX Oncology announced encouraging data from its Phase 1b/2 trial combining evorpacept and zanidatamab showing durable responses in HER2-positive metastatic breast cancer patients with high CD47 expression. The company is progressing well with its Phase 2 ASPEN-09-Breast trial targeting HER2-positive breast cancer with topline data expected mid-202…
Integra LifeSciences Holdings Corporation announced that its CFO, Lea Knight, will present at the BofA Securities 2026 Health Care Conference on May 12, 2026. The presentation will be webcast live on the company's investor relations website. The event highlights Integra LifeSciences' ongoing engagement with investors and its leadership position in …
MiMedx Group announces the commercial launch of G4Derm Plus, a novel flowable biomimetic matrix incorporating self-assembling peptide technology designed for complex wound management. The product has been cleared by the FDA and added to major group purchasing organization agreements (Premier and Vizient), enabling nationwide distribution to surgica…
Humacyte, a Nasdaq-listed biotechnology company developing bioengineered human tissues, announces it will release its first quarter 2026 financial results and provide a corporate update via webcast and conference call on May 13, 2026. The company specializes in acellular tissue engineered vessels (ATEVs) with FDA approval in vascular trauma and ong…
Alamar Biosciences announced nearly doubling its Q1 2026 revenue to $26 million driven by strong instrument placements and consumables sales. The company completed an IPO in April 2026 raising about $220 million net proceeds, strengthening its balance sheet to accelerate its Precision Proteomics platform adoption. Despite increased operating expens…
Moomoo Canada, an affiliate of Nasdaq-listed Futu Holdings Limited, announces 'Canada's Top Trader,' the first live, real-money national trading competition in Canada. The competition runs from June 1-30, 2026, using real capital on the moomoo platform with a prize pool of approximately $1 million CAD. Educational resources and workshops are provid…
Wrap Technologies, Inc. announced its participation in a major European law enforcement event in Italy to introduce its Non-Lethal Response ecosystem, including the BolaWrap device, immersive training platform WrapReality, and policy strategies. The company aims to expand adoption of its non-lethal public safety tools in Europe, highlighting operat…
CCH Holdings Ltd, a Malaysian specialty hotpot restaurant chain, announced the effective implementation of its dual-class share structure on the Nasdaq Capital Market. The company's ordinary shares have been redesignated as Class A ordinary shares, with Class B shares carrying enhanced voting rights. Trading under the symbol CCHH will continue from…
Pacira BioSciences granted inducement awards, including stock options and restricted stock units, to ten new employees to incentivize employment under its Amended and Restated 2014 Inducement Plan. The awards were approved by the Board's People & Compensation Committee without stockholder approval. The grants include options exercisable at $24.69 p…
BioCardia announced FDA's agreement on two possible regulatory pathways for market clearance of its Helix Transendocardial Delivery Catheter System. The FDA showed no concerns regarding safety or device performance and prefers simultaneous approval with CardiAMP Cell Therapy. BioCardia aims to pursue both pathways to accelerate commercial opportuni…
Kratos Defense & Security Solutions has chosen Odon, Indiana as the location for its new mid-tier coupled arc jet and laser test facility under Project Helios. This facility aims to bridge the gap between laboratory material development and operational use for hypersonic systems, expanding the U.S. aerothermal testing infrastructure and supporting …
3 E Network Technology Group Limited announced a $1.3 million convertible note financing aimed at advancing its semiconductor and AI infrastructure development. The company officially established its Chip Business Unit to develop proprietary core storage chips, acquire critical IP and design tools, and secure manufacturing capacity. This strategic …
Plains All American Pipeline, L.P. reported solid first-quarter 2026 financial results, with net income attributable to PAA of $152 million and net cash provided by operating activities of $418 million. The company increased its full-year 2026 Adjusted EBITDA guidance midpoint by $130 million to $2.88 billion, citing a strong oil macro environment …
Traws Pharma, a clinical-stage biopharmaceutical company listed on NASDAQ, announced plans to advance clinical candidates targeting hantavirus infections, which currently have no approved treatments and carry a high fatality rate. Building on its expertise in antiviral drugs for negative-strand RNA viruses, Traws aims to rapidly identify and develo…
Plus Therapeutics announced that key clinical and translational data from their Phase 1 ReSPECT-LM trial of REYOBIQ were presented at the 2026 American Association of Neurological Surgeons meeting. The data demonstrated encouraging survival outcomes, favorable safety profiles, and potential immune-modulatory effects in treating leptomeningeal metas…
Exodus Movement, Inc. has launched XO Cash, the first stablecoin specifically designed for AI agents, enabling secure and self-custodial spending by AI agents without requiring them to manage private keys. The product integrates with Exodus Pay on the Solana blockchain and offers developer tools to create agent wallets with customizable spending ru…
iBio, a NASDAQ-listed biotechnology company, has appointed Elizabeth Stoner, M.D., M.S., a seasoned biotech executive, to its Board of Directors. The move comes as iBio prepares to initiate its first human clinical trials for treatments targeting obesity and pulmonary hypertension associated with heart failure. Stoner's extensive experience in biot…
Treace Medical Concepts reported first quarter 2026 revenue of $47.2 million, a 10% decrease compared to Q1 2025, with a net loss of $18.0 million. The company launched its SuperBite™ Compression Screw System and expanded its patent portfolio. Despite the revenue decline, it reaffirmed its full-year 2026 revenue guidance of $202 million to $212 mil…
Sagtec Global Limited announces its partner Stateight Sdn Bhd has won the Asia Pacific Property Award 2026-2027 for a residential development project in Malaysia. This award reinforces Sagtec's ongoing collaboration in funding and providing AI Smart Home solutions for an 84-unit townhouse project, integrating advanced smart home technologies and ex…
GigaCloud Technology Inc announced that its CEO, Larry Wu, will present at the 21st Annual Needham Technology, Media, & Consumer Conference. The company, specializing in end-to-end B2B ecommerce technology solutions for large parcel merchandise, will also host virtual investor meetings during the event.
Tvardi Therapeutics announced its first quarter 2026 financial results and provided updates on its clinical programs targeting STAT3-driven diseases. The company expects topline data for its next-generation STAT3 inhibitor TTI-109 from a healthy volunteer study in June 2026 and Phase 1b/2 trial results for TTI-101 in hepatocellular carcinoma in the…
MapLight Therapeutics, a clinical-stage biopharmaceutical company specializing in central nervous system disorders, announced its management team's participation in the 2026 RBCCM Global Healthcare Conference and the 2026 Jefferies Global Healthcare Conference. The company focuses on developing circuit-specific pharmacotherapies using a novel disco…
TeraWulf Inc. reported its Q1 2026 financial results showing $34.0 million total revenue including $21.0 million from high-performance computing (HPC) lease revenue, highlighting its transition towards stable, contracted revenue. The company energized 60 MW of HPC capacity at its Lake Mariner facility, progressing on key construction projects, and …
